R21/Matrix-M vaccine, developed by the University of Oxford, is the first malaria vaccine to reach 75% efficacy target
A highly effective malaria vaccine has been recommended for widespread use by the World Health Organization.
The R21/Matrix-M vaccine, developed by the University of Oxford, is only the second malaria vaccine to be recommended by the WHO. It is the first to meet the WHO’s target of 75% efficacy.
Malaria, a mosquito-borne disease, claims half a million lives every year and mostly affects children under the age of five, and pregnant women.
“As a malaria researcher, I used to dream of the day we would have a safe and effective vaccine against malaria. Now we have two,” said Dr Tedros Adhanom Ghebreyesus, director general of the WHO.
Kinda sad how much the WHO has fallen in public perception after COVID. Almost worth replacing them or something.
They’ve not fallen in perception to those whose medical opinion matters
